RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Subnational projections of Lymphatic Filariasis Elimination Targets in Ethiopia to Support National Level Policy
Prada, J. M., Touloupou, P., Kebede, B., Giorgi, E., Sime, H., Smith, M., Kontoroupis, P., Brown, P., Cano, J., Farkas, H., Irvine, M., Reimer, L., Caja Rivera, R., de Vlas, S. J., Michael, E., Stolk, W. A., Pulan, R., Spencer, S. E. F., Hollingsworth, T. D., & Seife, F. (2024). Subnational projections of Lymphatic Filariasis Elimination Targets in Ethiopia to Support National Level Policy. Clinical Infectious Diseases, 78(Supplement_2), S117-S125. https://doi.org/10.1093/cid/ciae072
BACKGROUND: Lymphatic filariasis (LF) is a debilitating, poverty-promoting, neglected tropical disease (NTD) targeted for worldwide elimination as a public health problem (EPHP) by 2030. Evaluating progress towards this target for national programmes is challenging, due to differences in disease transmission and interventions at the subnational level. Mathematical models can help address these challenges by capturing spatial heterogeneities and evaluating progress towards LF elimination and how different interventions could be leveraged to achieve elimination by 2030.
METHODS: Here we used a novel approach to combine historical geo-spatial disease prevalence maps of LF in Ethiopia with 3 contemporary disease transmission models to project trends in infection under different intervention scenarios at subnational level.
RESULTS: Our findings show that local context, particularly the coverage of interventions, is an important determinant for the success of control and elimination programmes. Furthermore, although current strategies seem sufficient to achieve LF elimination by 2030, some areas may benefit from the implementation of alternative strategies, such as using enhanced coverage or increased frequency, to accelerate progress towards the 2030 targets.
CONCLUSIONS: The combination of geospatial disease prevalence maps of LF with transmission models and intervention histories enables the projection of trends in infection at the subnational level under different control scenarios in Ethiopia. This approach, which adapts transmission models to local settings, may be useful to inform the design of optimal interventions at the subnational level in other LF endemic regions.
